Restated Consolidated Statements of Cash Flows - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 9 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Sep. 30, 2025 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Cash flows provided by operating activities: | |||||||||||||||
| Net income | $ (284,183) | $ 203,516 | $ 160,812 | $ 213,268 | $ 82,776 | $ 148,337 | $ 153,901 | $ 108,045 | $ 108,877 | $ 364,328 | $ 231,113 | $ 216,922 | $ 80,145 | $ 444,381 | $ 370,823 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||
| Depreciation and amortization expense | 95,958 | 149,181 | 145,126 | 193,676 | 298,816 | 290,185 | 292,706 | 391,845 | 436,217 | ||||||
| Goodwill impairment | 364,248 | 0 | 0 | 0 | 0 | 364,248 | 0 | 0 | |||||||
| Impairment of non-financial assets | 101,027 | 0 | 0 | 0 | 0 | 101,027 | 0 | 0 | |||||||
| Impairment of operating right-of-use assets and related property, plant and equipment | 0 | 0 | 6,933 | 5,573 | 12,559 | 8,613 | 5,573 | 12,559 | 8,845 | ||||||
| Reduction in carrying value of operating right-of-use assets | 9,384 | 11,472 | 11,304 | 18,977 | 19,367 | 23,607 | 29,473 | 29,820 | 33,979 | ||||||
| Loss on equity method investments | 0 | 0 | 383 | 383 | 383 | ||||||||||
| Acquisition-related gain | 0 | (6,160) | (6,160) | ||||||||||||
| Amortization of financing costs and debt discount | 1,480 | 3,907 | 4,497 | 2,971 | 20,604 | 7,899 | 4,470 | 22,066 | 12,485 | ||||||
| Stock compensation expense | 12,359 | 13,181 | 14,759 | 27,610 | 28,145 | 31,357 | 72,529 | 41,183 | 47,303 | ||||||
| Deferred tax benefit | (25,014) | (34,757) | (44,413) | (46,095) | (60,209) | (60,355) | (114,257) | (85,646) | (116,367) | ||||||
| Unrealized foreign exchange movements | 18,081 | (1,027) | (1,319) | 34,777 | 13,761 | (3,345) | 24,661 | 34,018 | (7,670) | ||||||
| Other non-cash items | 8,240 | 4,629 | 17,534 | 15,266 | 12,463 | 18,202 | 20,561 | 26,828 | 21,966 | ||||||
| Changes in operating assets and liabilities: | |||||||||||||||
| Accounts receivable | 481 | 53,600 | (93,259) | 15,149 | 173,821 | (40,675) | (8,212) | 326,877 | (139,096) | ||||||
| Unbilled revenue | (66,376) | (97,327) | 90,759 | (138,521) | (176,109) | 70,760 | (157,162) | (279,550) | 143,058 | ||||||
| Unearned revenue | 23,463 | 20,284 | (18,970) | 25,761 | (22,289) | (14,642) | 64,542 | (92,192) | 59,034 | ||||||
| Other net assets | 29,372 | 55,596 | (66,711) | (105,031) | (6,377) | (163,370) | 21,739 | 76,149 | (143,904) | ||||||
| Net cash provided by operating activities | 268,240 | 327,076 | 175,500 | 414,441 | 545,665 | 379,381 | 802,043 | 948,338 | 720,896 | ||||||
| Cash flows used in investing activities: | |||||||||||||||
| Purchase of property, plant and equipment | (28,907) | (27,152) | (26,744) | (61,185) | (63,440) | (58,880) | (114,885) | (106,772) | (87,980) | ||||||
| Purchase of subsidiary undertakings (net of cash acquired) | (2,537) | (7,831) | 0 | (2,537) | (7,831) | (5,100) | (2,537) | (85,629) | (5,100) | ||||||
| Movement of available for sale investments | (1) | 60 | 1,954 | 60 | 1,954 | (241) | |||||||||
| Proceeds from investments in equity | 103 | 0 | 561 | 1,373 | 2,114 | 2,671 | |||||||||
| Purchase of investments in equity | (5,941) | (4,381) | (1,358) | (12,330) | (5,621) | (4,733) | (16,286) | (10,131) | (10,829) | ||||||
| Net cash used in investing activities | (37,282) | (39,365) | (28,042) | (75,491) | (73,565) | (68,653) | (131,594) | (197,907) | (104,150) | ||||||
| Cash flows used in financing activities: | |||||||||||||||
| Debt issue costs | 0 | (11,679) | (12,678) | ||||||||||||
| Drawdown of credit lines and loan facilities | 50,000 | 50,000 | 180,000 | 50,000 | 2,192,480 | 230,000 | 50,000 | 2,242,480 | 305,000 | ||||||
| Repayment | (57,440) | (330,000) | (350,000) | (64,881) | (2,537,882) | (580,000) | (72,321) | (2,595,323) | (930,000) | ||||||
| Proceeds from exercise of equity compensation | 4,763 | 16,305 | 12,940 | 6,498 | 21,645 | 20,177 | 7,319 | 32,379 | 36,517 | ||||||
| Share issue costs | (5) | (4) | (4) | (9) | (14) | (9) | (14) | (17) | (14) | ||||||
| Repurchase of ordinary shares | (250,000) | 0 | (500,000) | 0 | (750,000) | (100,000) | |||||||||
| Share repurchase costs | (150) | 0 | (300) | 0 | (450) | (68) | |||||||||
| Net cash used in financing activities | (252,832) | (263,699) | (157,064) | (508,692) | (335,450) | (329,832) | (765,466) | (433,227) | (588,497) | ||||||
| Effect of exchange rate movements on cash | 9,787 | (6,032) | 718 | 21,353 | (8,199) | 512 | 25,120 | 201 | (3,952) | ||||||
| Net (decrease) / increase in cash and cash equivalents | (12,087) | 17,980 | (8,888) | (148,389) | 128,451 | (18,592) | (69,897) | 317,405 | 24,297 | ||||||
| Cash and cash equivalents at beginning of period | 390,396 | 526,698 | 538,785 | 506,553 | 396,082 | 378,102 | 270,176 | 279,880 | 288,768 | 538,785 | 378,102 | 288,768 | 538,785 | 378,102 | 288,768 |
| Cash and cash equivalents at end of period | 468,888 | 390,396 | 526,698 | 695,507 | 506,553 | 396,082 | 313,065 | 270,176 | 279,880 | 390,396 | 506,553 | 270,176 | 468,888 | 695,507 | 313,065 |
| As Reported | |||||||||||||||
| Cash flows provided by operating activities: | |||||||||||||||
| Net income | 2,355 | 182,972 | 154,151 | 197,128 | 146,910 | 187,438 | 163,665 | 115,598 | 116,654 | 337,123 | 334,348 | 232,252 | 339,478 | 531,476 | 395,917 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||
| Depreciation and amortization expense | 95,958 | 149,181 | 145,126 | 193,676 | 298,816 | 290,185 | 292,171 | 391,845 | 436,217 | ||||||
| Goodwill impairment | 165,300 | 0 | 0 | 165,300 | |||||||||||
| Impairment of non-financial assets | 0 | 0 | 0 | 0 | |||||||||||
| Impairment of operating right-of-use assets and related property, plant and equipment | 0 | 0 | 6,933 | 5,573 | 12,559 | 8,613 | 5,573 | 12,559 | 8,845 | ||||||
| Reduction in carrying value of operating right-of-use assets | 9,384 | 11,472 | 11,304 | 18,977 | 19,367 | 23,607 | 29,473 | 29,820 | 33,979 | ||||||
| Loss on equity method investments | 0 | 0 | 383 | 383 | 383 | ||||||||||
| Acquisition-related gain | 0 | (6,160) | (6,160) | ||||||||||||
| Amortization of financing costs and debt discount | 1,480 | 3,907 | 4,497 | 2,971 | 20,604 | 7,899 | 4,470 | 22,066 | 12,485 | ||||||
| Stock compensation expense | 12,359 | 13,181 | 14,759 | 27,610 | 28,145 | 31,357 | 72,529 | 41,183 | 47,303 | ||||||
| Deferred tax benefit | (25,014) | (35,145) | (43,823) | (46,095) | (61,239) | (59,177) | (91,788) | (86,579) | (114,487) | ||||||
| Unrealized foreign exchange movements | 18,081 | (1,027) | (1,319) | 34,777 | 13,761 | (3,345) | 24,661 | 34,018 | (7,670) | ||||||
| Other non-cash items | 8,240 | 4,629 | 17,534 | 15,266 | 12,463 | 18,202 | 20,561 | 26,828 | 21,966 | ||||||
| Changes in operating assets and liabilities: | |||||||||||||||
| Accounts receivable | 9,706 | (80,431) | (93,259) | 24,374 | 198,749 | (40,675) | 1,013 | 352,795 | (139,096) | ||||||
| Unbilled revenue | 84,155 | (42,546) | (18,346) | 36,040 | (287,183) | (27,210) | 25,979 | (423,533) | 14,370 | ||||||
| Unearned revenue | (122,305) | 56,485 | 80,990 | (122,306) | (52,081) | 65,266 | (101,089) | (72,930) | 158,269 | ||||||
| Other net assets | 22,045 | 59,932 | (65,933) | (113,545) | 7,356 | (161,816) | 13,712 | 88,790 | (141,425) | ||||||
| Net cash provided by operating activities | 268,240 | 327,076 | 175,500 | 414,441 | 545,665 | 379,381 | 802,043 | 948,338 | 720,896 | ||||||
| Cash flows used in investing activities: | |||||||||||||||
| Purchase of property, plant and equipment | (28,907) | (27,152) | (26,744) | (61,185) | (63,440) | (58,880) | (114,885) | (106,772) | (87,980) | ||||||
| Purchase of subsidiary undertakings (net of cash acquired) | (2,537) | (7,831) | 0 | (2,537) | (7,831) | (5,100) | (2,537) | (85,629) | (5,100) | ||||||
| Movement of available for sale investments | (1) | 60 | 1,954 | 60 | 1,954 | (241) | |||||||||
| Proceeds from investments in equity | 103 | 0 | 561 | 1,373 | 2,114 | 2,671 | |||||||||
| Purchase of investments in equity | (5,941) | (4,381) | (1,358) | (12,330) | (5,621) | (4,733) | (16,286) | (10,131) | (10,829) | ||||||
| Net cash used in investing activities | (37,282) | (39,365) | (28,042) | (75,491) | (73,565) | (68,653) | (131,594) | (197,907) | (104,150) | ||||||
| Cash flows used in financing activities: | |||||||||||||||
| Debt issue costs | 0 | (11,679) | (12,678) | ||||||||||||
| Drawdown of credit lines and loan facilities | 50,000 | 50,000 | 180,000 | 50,000 | 2,192,480 | 230,000 | 50,000 | 2,242,480 | 305,000 | ||||||
| Repayment | (57,440) | (330,000) | (350,000) | (64,881) | (2,537,882) | (580,000) | (72,321) | (2,595,323) | (930,000) | ||||||
| Proceeds from exercise of equity compensation | 4,763 | 16,305 | 12,940 | 6,498 | 21,645 | 20,177 | 7,319 | 32,379 | 36,517 | ||||||
| Share issue costs | (5) | (4) | (4) | (9) | (14) | (9) | (14) | (17) | (14) | ||||||
| Repurchase of ordinary shares | (250,000) | 0 | (500,000) | 0 | (750,000) | (100,000) | |||||||||
| Share repurchase costs | (150) | 0 | (300) | 0 | (450) | (68) | |||||||||
| Net cash used in financing activities | (252,832) | (263,699) | (157,064) | (508,692) | (335,450) | (329,832) | (765,466) | (433,227) | (588,497) | ||||||
| Effect of exchange rate movements on cash | 9,787 | (6,032) | 718 | 21,353 | (8,199) | 512 | 25,120 | 201 | (3,952) | ||||||
| Net (decrease) / increase in cash and cash equivalents | (12,087) | 17,980 | (8,888) | (148,389) | 128,451 | (18,592) | (69,897) | 317,405 | 24,297 | ||||||
| Cash and cash equivalents at beginning of period | 390,396 | 526,698 | 538,785 | 506,553 | 396,082 | 378,102 | 270,176 | 279,880 | 288,768 | 538,785 | 378,102 | 288,768 | 538,785 | 378,102 | 288,768 |
| Cash and cash equivalents at end of period | 468,888 | 390,396 | 526,698 | 695,507 | 506,553 | 396,082 | 313,065 | 270,176 | 279,880 | 390,396 | 506,553 | 270,176 | 468,888 | 695,507 | 313,065 |
| Adjustments | |||||||||||||||
| Cash flows provided by operating activities: | |||||||||||||||
| Net income | (286,538) | 20,544 | 6,661 | 16,140 | (64,134) | (39,101) | (9,764) | (7,553) | (7,777) | 27,205 | (103,235) | (15,330) | (259,333) | (87,095) | (25,094) |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||
| Depreciation and amortization expense | 0 | 0 | 0 | 0 | 0 | 0 | 535 | 0 | 0 | ||||||
| Goodwill impairment | 198,948 | 0 | 0 | 198,948 | |||||||||||
| Impairment of non-financial assets | 101,027 | 0 | 0 | 101,027 | |||||||||||
| Impairment of operating right-of-use assets and related property, plant and equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Reduction in carrying value of operating right-of-use assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Loss on equity method investments | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Acquisition-related gain | 0 | 0 | 0 | ||||||||||||
| Amortization of financing costs and debt discount | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Stock compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred tax benefit | 0 | 388 | (590) | 0 | 1,030 | (1,178) | (22,469) | 933 | (1,880) | ||||||
| Unrealized foreign exchange movements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other non-cash items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Changes in operating assets and liabilities: | |||||||||||||||
| Accounts receivable | (9,225) | 134,031 | 0 | (9,225) | (24,928) | 0 | (9,225) | (25,918) | 0 | ||||||
| Unbilled revenue | (150,531) | (54,781) | 109,105 | (174,561) | 111,074 | 97,970 | (183,141) | 143,983 | 128,688 | ||||||
| Unearned revenue | 145,768 | (36,201) | (99,960) | 148,067 | 29,792 | (79,908) | 165,631 | (19,262) | (99,235) | ||||||
| Other net assets | 7,327 | (4,336) | (778) | 8,514 | (13,733) | (1,554) | 8,027 | (12,641) | (2,479) | ||||||
| Net cash provided by operating activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Cash flows used in investing activities: | |||||||||||||||
| Purchase of property, plant and equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Purchase of subsidiary undertakings (net of cash acquired) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Movement of available for sale investments | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
| Proceeds from investments in equity | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
| Purchase of investments in equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Net cash used in investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Cash flows used in financing activities: | |||||||||||||||
| Debt issue costs | 0 | 0 | 0 | ||||||||||||
| Drawdown of credit lines and loan facilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Proceeds from exercise of equity compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Share issue costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Repurchase of ordinary shares | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
| Share repurchase costs | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
| Net cash used in financing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Effect of exchange rate movements on cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Net (decrease) / increase in cash and cash equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Cash and cash equivalents at beginning of period | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and cash equivalents at end of period | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 |